Business

B.R.Goyal Infrastructure Limited Received In-Principle Approval From BSE

Nov 22, 2024

PNN
Mumbai (Maharashtra) [India], November 22: The Bombay Stock Exchange has approved the Draft Red Herring Prospectus of B.R.Goyal Infrastructure Limited for its upcoming Initial Public Offering .B.R.Goyal Infrastructure intends to pursue inorganic growth through acquisitions and other strategic initiatives. The company plans to raise funds through a fresh issue of 64,32,000 equity shares, each with a face value of Rs10, which will be used to support its capital expenditure, meet working capital requirements, and fuel its growth plans.
Beeline Capital Advisors Private Limited has been appointed as the Book Running Lead Manager to the Issue, while Link Intime India Private Limited will serve as the Registrar to the Issue.
About B.R.Goyal Infrastructure Limited:
B.R.Goyal Infrastructure Limited is a premier construction and infrastructure development company with expertise in civil construction, ready-mix concrete manufacturing, wind power generation, toll collection, and residential plotting. The company provides comprehensive EPC services for roads, highways, commercial complexes, industrial parks, housing projects, and HAM projects, primarily serving government departments.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by PNN. ANI will not be responsible in any way for the content of the same)

More news

Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month

Mumbai (Maharashtra) [India], November 22: Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. In India, it continues to be a leading cause of cancer-related mortality. However, advancements in early detection and new treatment options, particularly genetic profiling, are improving survival rates. These innovations are part of precision oncology, a rapidly growing field that customizes treatments based on a patient's unique genetic makeup, enabling personalized care.

Nov 22, 2024